Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Improvement of neurological disorders in postmenopausal model rats by administration of royal jelly.
Tiam1/Rac1 complex controls Il17a transcription and autoimmunity.
Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: Implication for disease pathogenesis.
Familial amyotrophic lateral sclerosis with an I104F mutation in the SOD1 gene: Multisystem degeneration with neurofilamentous aggregates and SOD1 inclusions.
Zeb2 is essential for Schwann cell differentiation, myelination and nerve repair.
Fingolimod-induced leukoencephalopathy in a patient with neuromyelitis optica spectrum disorder.
Atf6α deficiency suppresses microglial activation and ameliorates pathology of experimental autoimmune encephalomyelitis.
Increased regional gray matter atrophy and enhanced functional connectivity in male multiple sclerosis patients.
Recombinant Antibody Fragments For Neurodegenerative Diseases.
Pseudo-Foster Kennedy Syndrome as a Rare Presentation of Vitamin B12 Deficiency.
Relapsed Acute Lymphoblastic Leukemia Presenting as Optic Neuritis.
The role of microRNAs in the pathogenesis of autoimmune diseases.
Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis.
Safety of switching from natalizumab straight into fingolimod in a group of JCV-positive patients with multiple sclerosis.
Schwann cell differentiation inhibits interferon-gamma induction of expression of major histocompatibility complex class II and intercellular adhesion molecule-1.
Decreased soluble IFN-β receptor (sIFNAR2) in multiple sclerosis patients: A potential serum diagnostic biomarker.
Effect of melatonin supplementation on plasma lipid hydroperoxides, homocysteine concentration and chronic fatigue syndrome in multiple sclerosis patients treated with interferons-beta and mitoxantrone.
Diagnostic Criteria for Psychosomatic Research and Psychosocial Functioning in Multiple Sclerosis.
A human anti-polysialic acid antibody as a potential treatment to improve function in multiple sclerosis patients.
Tuning PAK Activity to Rescue Abnormal Myelin Permeability in HNPP.
Autoantibodies against glutamate receptor δ2 after allogenic stem cell transplantation.
Cutaneous and Mixed Nerve Silent Period Recordings in Symptomatic Paroxysmal Kinesigenic Dyskinesia.
Nerve conduction velocity in CMT1A: what else can we tell?
Antibody-Mediated Autoimmune Encephalitis in Childhood.
Discontinuation of disease-modifying therapies in multiple sclerosis - Clinical outcome and prognostic factors.

Pages